Fate Therapeutics, Inc.
Fate Therapeutics, Inc.（FATE）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
fate · 股价预测 · 31 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 31 位华尔街分析师
Buy
31 位分析师
共识
评级分布
12 个月目标价
High
$7.00
Consensus
$5.50
+188.0% upside
Low
$4.00
Median: $5.5 · Last Close: $1.91
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$5.50
188.0% upside
High Target
$7
266.5%
Low Target
$4
109.4%
Current Price
$1.91
as of today
Based on analyst price targets, the FATE stock price prediction for the next 12 months ranges from $4 to $7. The consensus FATE price forecast of $5.50 implies 188.0% upside from the current price of $1.91.
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.91 | ↓ 0.23% |
1-day model range: $1.87–$1.94. Peak: $1.94 (-0.23%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -50.0% |
| 2028 | $1 | -62.5% |
| 2029 | $1 | -67.2% |
| 2030 | $1 | -69.2% |
| 2031 | — | -70.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · FATE · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-31 | HC Wainwright & Co. | Upgrade ↑ | Neutral→Buy |
| 2025-10-27 | Needham | Maintains | Hold→Hold |
| 2025-10-27 | Wedbush | Upgrade ↑ | Neutral→Outperform |
| 2025-08-13 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
| 2025-06-12 | Needham | Maintains | Hold→Hold |
| 2025-05-14 | Baird | Maintains | Neutral→Neutral |
| 2025-05-14 | Barclays | Maintains | Overweight→Overweight |
| 2025-05-14 | Needham | Maintains | Hold→Hold |
| 2025-03-06 | Wedbush | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on Fate Therapeutics, Inc. (FATE) stock. Of the recent 129 rating actions, 9 were upgrades and 14 were downgrades. 31 analysts currently cover FATE.
分析师推荐趋势
FATE analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$5M
↑ 2.6% YoY
Revenue Next Year
$5M
↓ 0.5% YoY
EPS This Year
$-1.08
EPS Next Year
$-0.97
↓ 10.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast FATE EPS of $-1.08 for the current fiscal year, based on estimates from 9 analysts. The FATE revenue forecast is $5M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
FATE 股价预测由两类独立数据源支撑：来自 31 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。FATE 的共识目标价为 $5.50（+188.0% 上行空间），分析师共识为 Buy。
FATE 的短期预测（明日）为 $1.91（-0.23%）。 FATE 对 2027 年的股价预测均值为 $1。 FATE 对 2030 年的预测区间为 $0–$1。
Fate Therapeutics, Inc. 在 NASDAQ 上市，代码 FATE。FATE 在 2027 年的整体展望偏积极，在覆盖分析师中约 52% 对应 Buy 共识。
常见问题
FATE 预测 · 8 个问题根据 31 位华尔街分析师，FATE 的 12 个月平均目标价为 $5.50，最高 $7.00、最低 $4.00。若有图表，中位目标价可在上方查看。相对当前价 $1.91，隐含约 +188.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.